By Tim McLaughlin | Jan 08, 2013 12:26 PM EST
The person hired to run the bankrupt pharmacy linked to a deadly U.S. meningitis outbreak is "hopelessly conflicted" and should be removed from the job, a U.S. Justice Department official said.
By David Morgan | Nov 19, 2012 04:56 PM EST
Republicans on a congressional panel investigating a deadly meningitis outbreak told FDA not to expect new authority to prevent future problems until the agency hands over documents about its role in the current crisis.
By Toni Clarke | Nov 09, 2012 11:30 AM EST
Ameridose LLC, an affiliate of NECC at the heart of the deadly U.S. meningitis outbreak, is laying off about 90 percent of its workforce.
By Makini Brice | Nov 08, 2012 11:22 AM EST
The director of NECC was fired because he had ignored a complaint lodged against the company in July.
By Amber Moore | Nov 02, 2012 10:11 AM EDT
Bacteria were found in the recent recalled products of the New England Compounding Center that has been associated with the recent meningitis outbreak.
By Makini Brice | Oct 29, 2012 12:15 PM EDT
Staffers at the New England Compounding Center knew of contamination in the pharmacy for months, but chose to do nothing.
By Toni Clarke & Caroline Humer | Oct 27, 2012 11:48 AM EDT
The FDA said it found "greenish black foreign matter" and other contaminants in an injectable steroid produced by the New England Compounding Center.
By Toni Clarke & Sharon Begley | Oct 27, 2012 11:31 AM EDT
Interviews with former NECC employees and a review of internal documents and state records show how regulators failed to punish the company despite repeated violations of the rules.
By Nick Brown | Oct 24, 2012 11:39 AM EDT
Victims of a deadly U.S. meningitis outbreak are starting to sue the physicians and clinics that administered tainted steroid shots, and the success of the suits could hinge on whether judges decide the injections are subject to product liability or medical malpractice laws.
By Bill Berkrot | Oct 23, 2012 11:02 AM EDT
The extended shutdown of a sister company of the pharmacy at the center of the deadly U.S. meningitis outbreak may exacerbate drug shortages for some hospitals and healthcare providers.
By Toni Clarke & Tim McLaughlin | Oct 23, 2012 10:54 AM EDT
The pharmacy tied to a deadly U.S. meningitis outbreak escaped harsh punishment from health regulators several times that has raised questions about oversight of the customized drug mixing industry.
By David Morgan | Oct 23, 2012 09:05 AM EDT
U.S. and Massachusetts state health regulators were aware in 2002 that steroid treatments from the pharmacy at the center of a deadly meningitis outbreak could cause adverse patient reactions.
By Tim McLaughlin & Bill Berkrot | Oct 20, 2012 10:20 AM EDT
Executives at the Boston-area pharmacy whose steroid shots have been linked to a deadly U.S. meningitis outbreak have been sued in a bid to freeze their personal assets.
By David Bailey & Tim Ghianni | Oct 20, 2012 10:06 AM EDT
The list of NECC products fills 70 pages. The FDA specifically advised doctors to alert patients who received injected NECC drugs during heart and eye surgeries that the company produced after May 21.
By Makini Brice | Oct 19, 2012 11:56 AM EDT
As the number of cases of fungal meningitis and joint infections has again increased during the nationwide outbreak, health officials have confirmed that the steroid injections that caused the outbreak were tainted with a fungus.
